S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?

Enovis (ENOV) Stock Price, News & Analysis

$62.38
-0.08 (-0.13%)
(As of 03/28/2024 ET)
Today's Range
$61.95
$62.62
50-Day Range
$58.70
$63.80
52-Week Range
$43.04
$66.14
Volume
351,475 shs
Average Volume
454,177 shs
Market Capitalization
$3.42 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$75.43

Enovis MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
20.9% Upside
$75.43 Price Target
Short Interest
Bearish
8.38% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.63mentions of Enovis in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
18.22%
From $2.58 to $3.05 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.01 out of 5 stars

Industrials Sector

10th out of 23 stocks

Specialty Industrial Machinery Industry

4th out of 4 stocks

ENOV stock logo

About Enovis Stock (NYSE:ENOV)

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

ENOV Stock Price History

ENOV Stock News Headlines

ENOV Dec 2024 60.000 put
Claim Your Complimentary Bitcoin Reward
Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.
ENOV Mar 2024 60.000 put
ENOV Jun 2024 50.000 put
Warning: this could blow your mind
Buckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…
Q4 2023 Enovis Corp Earnings Call
Enovis Announces Fourth Quarter and Full Year 2023 Results
Enovis Announces Fourth Quarter and Full Year 2023 Results
Enovis Corporation Q4 2023 Earnings Preview
ENOV Mar 2024 70.000 call
5 Analysts Have This To Say About Enovis
See More Headlines
Receive ENOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enovis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/22/2024
Today
3/29/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Specialty Industrial Machinery
Sub-Industry
N/A
Employees
6,550
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$75.43
High Stock Price Target
$82.00
Low Stock Price Target
$70.00
Potential Upside/Downside
+20.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

Net Income
$-33,260,000.00
Pretax Margin
-3.93%

Debt

Sales & Book Value

Annual Sales
$1.71 billion
Cash Flow
$6.62 per share
Book Value
$62.66 per share

Miscellaneous

Free Float
51,834,000
Market Cap
$3.42 billion
Optionable
Optionable
Beta
1.98
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

ENOV Stock Analysis - Frequently Asked Questions

Should I buy or sell Enovis stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Enovis in the last twelve months. There are currently 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ENOV shares.
View ENOV analyst ratings
or view top-rated stocks.

What is Enovis' stock price target for 2024?

8 brokers have issued 12-month target prices for Enovis' shares. Their ENOV share price targets range from $70.00 to $82.00. On average, they expect the company's stock price to reach $75.43 in the next twelve months. This suggests a possible upside of 20.9% from the stock's current price.
View analysts price targets for ENOV
or view top-rated stocks among Wall Street analysts.

How have ENOV shares performed in 2024?

Enovis' stock was trading at $56.02 at the beginning of 2024. Since then, ENOV shares have increased by 11.4% and is now trading at $62.38.
View the best growth stocks for 2024 here
.

When is Enovis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our ENOV earnings forecast
.

How were Enovis' earnings last quarter?

Enovis Co. (NYSE:ENOV) issued its earnings results on Thursday, February, 22nd. The company reported $0.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.76 by $0.03. The business earned $455 million during the quarter, compared to the consensus estimate of $444.34 million. Enovis had a positive trailing twelve-month return on equity of 3.84% and a negative net margin of 1.95%. The company's revenue was up 11.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.72 earnings per share.

What ETFs hold Enovis' stock?
What guidance has Enovis issued on next quarter's earnings?

Enovis issued an update on its FY24 earnings guidance on Thursday, February, 22nd. The company provided EPS guidance of $2.50-$2.65 for the period, compared to the consensus earnings per share estimate of $2.70. The company issued revenue guidance of $2.05-$2.15 billion, compared to the consensus revenue estimate of $2.02 billion.

Who are Enovis' major shareholders?

Enovis' stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.98%), Vanguard Group Inc. (8.97%), Dimensional Fund Advisors LP (5.85%), DAVENPORT & Co LLC (3.44%), Channing Capital Management LLC (2.91%) and Allspring Global Investments Holdings LLC (1.89%). Insiders that own company stock include A Clayton Perfall, Bradley J Tandy, Brady Shirley, Christopher M Hix, Daniel A Pryor, John Kleckner, Matthew L Trerotola, Patricia A Lang, Phillip Benjamin (Ben) Berry and Rajiv Vinnakota.
View institutional ownership trends
.

How do I buy shares of Enovis?

Shares of ENOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:ENOV) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners